Placeholder
Browse by series
A legacy of innovation
Our story … starting with today
As one of the first CROs, we have a long heritage of product development. Beyond executing studies for our customers, our history reflects our commitment to innovate as we continually seek new ways to improve and enhance the drug development process.
2024
Fortrea focuses on core CRO services and value creation by spinning off FortreaRx™, patient access services and Endpoint Clinical
2023
Fortrea spins off from Labcorp to focus on being the leading clinical services provider
2021
Covance changes name to Labcorp Drug Development
2020
Acquisition of technology to support decentralized clinical trials
2020
Acquisition of remote nursing offering
2019
Covance acquires RCRI, entering the MedTech market
2018
Acquisition of pharmacovigilance capabilities
2017
Covance acquires Chiltern, enhancing biotech expertise
2017
Covance acquires Endpoint Clinical, adding IRT and clinical supply management solutions
2015
Covance joins Labcorp, connecting research and diagnostics
2014
Acquisition of market access consulting
1997
Corning spins off Covance as a publicly traded company, forming one of the first CROs
1990s
Corning Incorporated acquires numerous best-of-class drug development companies
Let our scientific and strategic expertise work for you.
More from our insights
Lorem ipsum dolor
Nascetur nisl ad porttitor sociosqu vivamus. Tristique mauris netus pulvinar hendrerit id.
Lorem ipsum dolor
Nascetur nisl ad porttitor sociosqu vivamus. Tristique mauris netus pulvinar hendrerit id.
Lorem ipsum dolor
Nascetur nisl ad porttitor sociosqu vivamus. Tristique mauris netus pulvinar hendrerit id.